Associated Papers
Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank.
Rioux B et al.
Nature Communications, 2026
41593088 (PubMed )
Supplement: 41467_2025_67832_MOESM1_ESM.pdf
TREX1 exonuclease in immunity and disease.
Shang Z et al.
International Immunology, 2025
Discordant phenotype caused by TREX1 variant in siblings with Aicardi-Goutières syndrome.
Liu R et al.
Pediatric Rheumatology Online Journal, 2025
Prevalence and impact of molecular variation in the three-prime repair exonuclease 1 TREX1 and its implications for oncology.
Shekfeh M et al.
Human Genomics, 2025
40581636 (PubMed )
Supplement: 40246_2025_785_MOESM11_ESM.xlsx › Table_S8
Neurophenotype and genetic analysis of children with Aicardi-Goutières syndrome in China.
Zhang S et al.
Pediatric Investigation, 2024
Aicardi-Goutières Syndrome Type 1: A Novel Missense Variant and Review of the Mutational Spectrum.
Tasharrofi B et al.
Iranian Journal of Child Neurology, 2024
A clinical score to guide in decision making for monogenic type I IFNopathies.
Sönmez HE et al.
Pediatric Research, 2020
TREX-1-Related Disease Associated with the Presence of Cryofibrinogenemia.
Paradis C et al.
Journal of Clinical Immunology, 2019
A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis.
Kisla Ekinci RM et al.
European Journal of Medical Genetics, 2017
Different Clinical Manifestations of Three Prime Repair Exonuclease 1 Mutation: A Case Series.
Incecik F et al.
Annals of Indian Academy of Neurology, 0
Select a paper to view details